NUCKS1
Basic information
Region (hg38): 1:205712822-205750182
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NUCKS1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 5 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 6 | 0 | 0 |
Variants in NUCKS1
This is a list of pathogenic ClinVar variants found in the NUCKS1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-205718341-G-A | not specified | Uncertain significance (Dec 15, 2022) | ||
1-205719642-T-G | not specified | Uncertain significance (Nov 18, 2022) | ||
1-205723953-T-C | not specified | Uncertain significance (Mar 02, 2023) | ||
1-205723981-A-G | not specified | Likely benign (Oct 03, 2024) | ||
1-205727734-T-C | not specified | Uncertain significance (Jan 09, 2023) | ||
1-205727805-T-C | not specified | Uncertain significance (Jun 03, 2022) | ||
1-205750014-C-CCGGGGGGGGGGGGGGGGGGGGGGGGG | not specified | Uncertain significance (May 04, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NUCKS1 | protein_coding | protein_coding | ENST00000367142 | 7 | 37458 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.969 | 0.0306 | 120217 | 0 | 1 | 120218 | 0.00000416 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.09 | 66 | 134 | 0.492 | 0.00000720 | 1613 |
Missense in Polyphen | 7 | 26.579 | 0.26337 | 298 | ||
Synonymous | 0.382 | 47 | 50.4 | 0.932 | 0.00000304 | 418 |
Loss of Function | 3.37 | 1 | 15.2 | 0.0658 | 8.77e-7 | 179 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000905 | 0.00000905 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
Recessive Scores
- pRec
- 0.133
Intolerance Scores
- loftool
- 0.301
- rvis_EVS
- -0.12
- rvis_percentile_EVS
- 44.54
Haploinsufficiency Scores
- pHI
- 0.901
- hipred
- Y
- hipred_score
- 0.728
- ghis
- 0.700
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.991
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Low | Medium |
Primary Immunodeficiency | Medium | Low | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nucks1
- Phenotype
Gene ontology
- Biological process
- double-strand break repair via homologous recombination;cellular glucose homeostasis;regulation of DNA replication;chromatin organization;regulation of transcription by RNA polymerase II;release from viral latency;replication fork processing;gene conversion;interstrand cross-link repair;positive regulation by host of viral transcription;positive regulation by host of viral genome replication;positive regulation of transcription by RNA polymerase II;regulation of insulin receptor signaling pathway;positive regulation of insulin receptor signaling pathway;regulation of DNA strand elongation;cellular response to X-ray;modulation by host of RNA binding by virus;modulation by host of viral RNA-binding transcription factor activity
- Cellular component
- chromatin;nuclear chromatin;nucleus;nucleolus;cytoplasm
- Molecular function
- DNA-binding transcription activator activity, RNA polymerase II-specific;chromatin binding;double-stranded DNA binding;single-stranded DNA binding;RNA binding;transcription factor binding